GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
Go back to GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa| AGENUS (NASDAQ: AGEN) | Delayed: 3.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $7.49 | |||
| Open | $3.04 | 52 Week Low | $2.61 | |||
| Day High | $3.04 | P/E | N/A | |||
| Day Low | $3.04 | EPS | $-1.10 | |||
| Volume | 1,021 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $50.74 | 52 Week Low | $37.82 | |||
| Day High | $50.74 | P/E | N/A | |||
| Day Low | $50.74 | EPS | $0.00 | |||
| Volume | 11,637 | |||||

